Clinical trial
Endothelin Receptor Blockade in Heart Failure With Diastolic Dysfunction and Pulmonary Hypertension
NCT00820352 is registered in ClinicalTrials.gov with University Teaching Hospital Hall in Tirol as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endothelin Receptor Blockade in Heart Failure With Diastolic Dysfunction and Pulmonary Hypertension
- Lead sponsor
- University Teaching Hospital Hall in Tirol
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- June 30, 2014
- Enrollment
- 20 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.